Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2008
08/20/2008EP1957102A2 Methods for inhibiting carcinogenesis and/or metastasis in an individual with endogenous c-met ligands and inhibitors
08/20/2008EP1957101A2 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants
08/20/2008EP1957100A1 Induction of mucosal tolerance to antigens
08/20/2008EP1957099A2 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
08/20/2008EP1956985A2 Allergy treatment by epicutaneous allergen administration
08/20/2008EP1583556B1 Sequences diagnostic for foot and mouth disease
08/20/2008EP1492402B1 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
08/20/2008EP1476558B1 Selection of poultry eimeria strains through extra-intestinal sporozoites
08/20/2008EP1446500B1 A method for regulating immune function in primates using the foxp3 protein
08/20/2008EP1409654B1 Immunological control of beta-amyloid levels in vivo
08/20/2008EP1356052B1 Production of full antibodies in procaryotic cells
08/20/2008EP1333850B1 Use of il-13 inhibitors for the treatment of tumors
08/20/2008EP1232262B1 Recombinant gelatin in vaccines
08/20/2008EP1142473B1 Compositions for acquiring immunological tolerance
08/20/2008EP1075493B1 Dna encoding snorf25 receptor
08/20/2008EP1044017B1 Supplement for dialysis patients
08/20/2008EP0885300B9 Transferrin receptor genes of moraxella
08/20/2008EP0797660B1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants
08/20/2008EP0724651B1 Synthetic human neutralizing monoclonal antibodies to human immunodeficiency virus
08/20/2008EP0587780B2 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
08/20/2008CN101248174A Attenuated SARS and use as a vaccine
08/20/2008CN101248173A Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
08/20/2008CN101248090A Polyclonal antiserum against a universal tumor antigen
08/20/2008CN101248088A Anti-il-23 antibodies
08/20/2008CN101248084A Tuberculosis vaccines comprising antigens expressed during the latent infection phase
08/20/2008CN101248083A NOGO receptor polypeptides and polypeptide fragments and uses thereof
08/20/2008CN101247830A TWEAK binding antibodies
08/20/2008CN101247829A Methods for treating fibrotic conditions
08/20/2008CN101247827A Immunogenic production process
08/20/2008CN101247826A Biodegradable nanoparticle having T-cell recognizable epitope peptide immobilized thereon or encapsulated therein
08/20/2008CN101247825A Dr5抗体及其用途 Dr5 antibodies and their use
08/20/2008CN101245107A Antihuman transferrin acceptor human source antibody and uses thereof
08/20/2008CN101245106A Anti-VRGF acceptor monoclone antibody, preparation method and application thereof
08/20/2008CN101245105A Anti-amyloid antibodies, compositions, methods and uses
08/20/2008CN101245101A Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146
08/20/2008CN101245100A Murine plague mycoprotein with immunity protection function, encoding gene and uses thereof
08/20/2008CN101245099A Amino acid sequence of recombined human papilloma virus L1 capsid protein and uses thereof
08/20/2008CN101244274A Ferrite/bacille calmette-guerin vaccine/temperature sensing gel rubber integration material and preparation thereof
08/20/2008CN101244270A Application of methionine enkephalin in preparing human or animal vaccination
08/20/2008CN101244269A Recombined foot and mouth disease virus amalgamation protein vaccine
08/20/2008CN101244268A Eimeria Tenella complex immunity regulation type DNA vaccine
08/20/2008CN101244267A Immunity preparation for reinforcing microorganism vaccine immunogenicity
08/20/2008CN100412193C Anti human CD19 mouse immune globulin variable zone gene and uses
08/20/2008CN100412188C Biologically active native biomatrix composition
08/20/2008CN100412092C Bacillus coli resisting chicken yolk antibody, its preparation and use
08/20/2008CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
08/20/2008CN100412089C Full-length infectious CDNA clones of tick borne flavivirus
08/20/2008CN100411685C Animal rabies virus suggarl mucleorrotein divalent DNA vaccine
08/20/2008CN100411617C Use of flavone compounds in preparing medicament
08/19/2008US7414123 Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
08/19/2008US7414120 enhances ubiquitination of phosphorylated I kappa B; human E3 ubiquitin ligase polypeptides; inflammatory diseases, autoimmune diseases, cancer and viral infections
08/19/2008US7414112 Of given sequence; conjugated to cytotoxic agent
08/19/2008US7414108 novel prostatic acid phosphatase and corresponding coding region derived from mouse; immunizing a subject with a xenogeneic polypeptide antigen, either alone, as part of a viral antigen construct, or as part of a pulsed dendritic cell preparation.
08/19/2008US7414035 hKIS composition and methods of use
08/19/2008US7414032 Vaccine comprising a polynucleotide encoding an antigen recognized by a CD4+ helper T-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a CD8+ CTL
08/19/2008US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody
08/19/2008US7413895 Nucleotide sequences coding cell surface protein associated with amino acid transport for use in identifying modlator for treatment and prevention of cell proliferative disorders; antitumor agents; antiproliferative agents
08/19/2008US7413889 Production of a parvovirus vaccine in plants as viral coat protein fusions
08/19/2008US7413884 Using antibodies as hydrolysis catalysts; reducing concentration of amyloid plaque
08/19/2008US7413865 Determine number of hematopoietic cells of erythroid, megakaryocyte or platelets; comparing amount of ankyrin and glycophorin to standard
08/19/2008US7413864 Treating cancer using a telomerase vaccine
08/19/2008US7413851 Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease
08/19/2008US7413756 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
08/19/2008US7413743 Active immunization using a siderophore receptor protein
08/19/2008US7413742 Clostridial toxin derivatives and methods for treating pain
08/19/2008US7413741 HCV E1 comprising specific disulfide bridges
08/19/2008US7413739 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
08/19/2008US7413738 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
08/19/2008US7413737 Complementarity determining regions which bind to catalytic domain of aspartyl (asparaginyl) beta -hydroxylase; diagnosis and treatment of cancer; readily penetrates tumors, no side effects, less toxic
08/19/2008US7413736 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein
08/19/2008US7413735 Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
08/19/2008US7413733 Transgenic lymphocytic cells comprising nucleotide sequences which code tumor, bacterial and or viral antigens for use as tools in delivering vaccines to disease bearing tissues
08/19/2008US7413728 Immune modulator
08/19/2008CA2578891A1 Medicaments for fungal infections
08/19/2008CA2442135C Methods to culture circovirus
08/19/2008CA2318372C A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/19/2008CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
08/14/2008WO2008098208A2 Gnaq mutations in melanoma
08/14/2008WO2008098145A1 Methods for modulating antigen-specific b cell responses
08/14/2008WO2008098115A2 Optimized igf-1r antibodies and methods of using the same
08/14/2008WO2008098042A1 Hybrid cells
08/14/2008WO2008097970A2 Canine influenza immunogenic compositions and methods of use thereof
08/14/2008WO2008097870A2 Agents that engage antigen - presenting cells through dendritic cell asialoglycoprotein receptor (dc- asgpr)
08/14/2008WO2008097866A2 Vaccines based on targeting antigen to dcir expressed an antigen-presenting cells
08/14/2008WO2008097863A2 Methods for producing yeast-based vaccines
08/14/2008WO2008097843A2 Rotary drill bit steerable system and method
08/14/2008WO2008097510A1 Antibodies specific for dkk-1
08/14/2008WO2008097467A1 Anti-methylation-controlled j protein antibodies and uses thereof
08/14/2008WO2008097267A2 Vaccines against vesicular stomatitis
08/14/2008WO2008097133A1 Medicinal agent for treating infectious diseases of domestic animals including diseases of viral etiology
08/14/2008WO2008097132A1 Medicinal agent for treating bird flu
08/14/2008WO2008096905A1 Anti-brak (cxcl14) human monoclonal antibody and use thereof
08/14/2008WO2008096831A1 Therapeutic agent for cancer
08/14/2008WO2008096242A1 Antibodies specific for varicella zoster virus
08/14/2008WO2008096131A1 Anti-pneumococcal capsular polysaccharide antibody molecules
08/14/2008WO2008095677A1 Recombinant antigens of human cytomegalovirus (hcmv)
08/14/2008WO2008095504A1 A polyclonal antibody product
08/14/2008WO2008095356A1 Methods of diagnosis of spinal muscular atrophy and treatments thereof
08/14/2008WO2008077077A3 Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
08/14/2008WO2008077022A9 Himf and btk in pulmonary, cardiac, and inflammation disorders